Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis 25 trials found
New Search
Filter
Trial Phase
Study Type
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
N/AOBSERVATIONAL Bethesda, Maryland +4 more
RECRUITING
Application of ihMT MRI in Multiple Sclerosis
NAINTERVENTIONAL Marseille, Paca +4 more
RECRUITING
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Delivery of a Culturally Tailored Exercise Training Intervention for Hispanics With Multiple Sclerosis
NAINTERVENTIONAL Houston, Texas
RECRUITING
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple Sclerosis
NAINTERVENTIONAL East Hanover, New Jersey +4 more
RECRUITING
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
NAINTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple Sclerosis
PHASE1INTERVENTIONAL Xi'an, Shaanxi
RECRUITING
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
N/AOBSERVATIONAL Bethesda, Maryland +4 more
RECRUITING
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
N/AOBSERVATIONAL Bethesda, Maryland +4 more
RECRUITING
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis
PHASE1, PHASE2INTERVENTIONAL Darlinghurst, New South Wales +4 more
RECRUITING
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Maitland, Florida +4 more
RECRUITING
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
N/AOBSERVATIONAL St Louis, Missouri +4 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Relationship Between Single- and Dual-Task Obstacle Crossing Performance and Fatigue and Disability in Multiple Sclerosis
N/AOBSERVATIONAL Afyonkarahisar, Merkez +4 more
RECRUITING
Immersive Virtual Reality and Exercise Programs in Multiple Sclerosis: ExeRVIEM III
NAINTERVENTIONAL Pontevedra +3 more
RECRUITING
Understanding and Enhancing Human Health and Movement
NAINTERVENTIONAL Cleveland, Ohio +3 more
RECRUITING
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
N/AOBSERVATIONAL Albstadt, Baden-Wurttemberg +4 more
RECRUITING
Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
NAINTERVENTIONAL Odense, Fyn +4 more
RECRUITING
Biomarkers in Autoimmune Disease of Nervous System
N/AOBSERVATIONAL Wuhan +4 more
RECRUITING
Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis
NAINTERVENTIONAL Baltimore, Maryland +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
PHASE4INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia
N/AOBSERVATIONAL Lawrenceville, New Jersey +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type